EMVision Receives $3.4m Non-Dilutive Funding this Quarter
Filed with ASX · · 2 pages · English
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Notification regarding unquoted securities - EMV
- Clinical Trial Data Drives Confidence for Expanded Studies
- AGM Chairmans Address & Presentation
- AGM Chairman's Address & Presentation
- FDA Breakthrough Device Application Update
Later from EMvision Medical Devices
- EMV Technology to be Presented at Prestigious Conference
- Application for quotation of securities - EMV
- S&P DJI Announces March 2022 Quarterly Rebalance
- New Appointments to Clinical Advisory Board
- EMVision Secures Strategic Agreement With Keysight
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices